To include your compound in the COVID-19 Resource Center, submit it here.

Alnylam completes upsized $805M follow-on

On Nov. 16, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $805 million through the sale

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE